Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.
Sleep medicine(2023)
摘要
This study demonstrates that 1500 mg FCM effectively treats RLS symptoms in IDA patients over six weeks, with MRI measurements of improved brain iron content serving as a potential biomarker for RLS patients.
更多查看译文
关键词
ferric carboxymaltose effects,iron deficiency anemia,brain iron,restless legs syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要